- Report
- May 2024
- 184 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- January 2024
- 150 Pages
Global
From €4608EUR$4,850USD£3,964GBP
- Report
- September 2021
- 74 Pages
Canada
From €5653EUR$5,950USD£4,863GBP
- Report
- May 2022
- 127 Pages
Global
From €5653EUR$5,950USD£4,863GBP
- Report
- July 2022
- 100 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- January 2019
- 156 Pages
Global
From €3026EUR$3,185USD£2,603GBP
€4323EUR$4,550USD£3,718GBP
- Report
- October 2021
- 116 Pages
Global
From €4275EUR$4,500USD£3,678GBP
- Report
- July 2021
- 114 Pages
Global
From €4228EUR$4,450USD£3,637GBP
- Report
- August 2023
- 112 Pages
Global
From €3500EUR$3,946USD£3,116GBP
The Varicose Vein Treatment Device market is a subset of the Cardiovascular Devices market. Varicose Vein Treatment Devices are used to treat varicose veins, a condition in which veins become enlarged, twisted, and visible through the skin. These devices are used to reduce the appearance of varicose veins and improve circulation. Varicose Vein Treatment Devices include laser treatments, radiofrequency ablation, and sclerotherapy.
The Varicose Vein Treatment Device market is driven by an aging population, increasing awareness of varicose veins, and technological advancements in the field. The market is expected to grow at a steady rate in the coming years.
Some companies in the Varicose Vein Treatment Device market include AngioDynamics, Inc., Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and Energist Ltd. Show Less Read more
